Title |
Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)
|
---|---|
Published in |
PLOS ONE, April 2009
|
DOI | 10.1371/journal.pone.0005134 |
Pubmed ID | |
Authors |
Kathy Boon, Nathaniel W. Bailey, Jun Yang, Mark P. Steel, Steve Groshong, Dolly Kervitsky, Kevin K. Brown, Marvin I. Schwarz, David A. Schwartz |
Abstract |
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic interstitial lung disease that is unresponsive to current therapy and often leads to death. However, the rate of disease progression differs among patients. We hypothesized that comparing the gene expression profiles between patients with stable disease and those in which the disease progressed rapidly will lead to biomarker discovery and contribute to the understanding of disease pathogenesis. |
Mendeley readers
The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 2% |
United Kingdom | 1 | <1% |
Germany | 1 | <1% |
Argentina | 1 | <1% |
Unknown | 97 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 17 | 17% |
Other | 14 | 14% |
Researcher | 14 | 14% |
Student > Bachelor | 12 | 12% |
Student > Master | 10 | 10% |
Other | 17 | 17% |
Unknown | 18 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 38% |
Agricultural and Biological Sciences | 18 | 18% |
Biochemistry, Genetics and Molecular Biology | 11 | 11% |
Nursing and Health Professions | 2 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 9 | 9% |
Unknown | 21 | 21% |